MENU CLOSE

Services

A Platform To Utilize Nasal Fluid
to Its Full Potential

scroll

The Noselab Advantage

Guiding you to utilizing the Brain-Nose Interface to its full potential

1

Sampling

2

Storage + Workup

3

Analytics

4

Data

5

Insight

Highest Sample Quality

  • Proprietary sampling device nosecollect®
  • Repeatable, optimal positioning for high quality nasal fluid collection
  • Large sample volume for multimodal analysis
  • Easy to use and minimal patient discomfort

Analytical Success

  • Optimized sample storage and workup
  • Established pre-analytics
  • Complete analytical workbench from proteomics via multi-target panels to single-target assays

Highest Quality Data

  • Fully analyzed biobank spanning various disorders
  • Enabling patient stratification and modelling
  • Fueling data-driven medicine

Sample Collection

Easy, safe and standardized collection of nasal fluid from the BNI

nosecollect®

nosecollect® is a proprietary class I medical device and specifically designed for the sampling of nasal fluid from the brain-nose interface.
The ready-to-use kit allows for easy handling by medical professionals and requires minimal training, making it highly accessible for routine clinical use. The complete procedure, including sample handling, takes less than 25 minutes.

The device provides a high absorption capacity, yielding sample volumes (mean ~ 0.5 ml) sufficient to support multi-analyses and biobanking.1 Clinical studies have shown a strong safety profile and excellent acceptance from both patients and healthcare providers.1

1) San Nicoló et al. (2025) Novel, standardized sample collection from the brain-nose interface. Methods. 2025 Feb;234:233-241.

Nasal Fluid Analytics

Noselab has established state-of-the-art analytical methods for nasal fluid

Mass Spectrometry

> 10,000 quantified proteins can be reproducibly quantified

Multi Target Panels

Excellent detectability in different panels (Olink Target 96 Neurology, Target 48 Neurodegeneration, NULISA CNS)

Single Target Assays

Quantification of disease-relevant proteins, including Amyloid-beta, Tau proteins

Biobanking and Data Modelling

The only reference data base of nasal fluid from the BNI

Clinical Network

  • Broad umbrella ethics approval:
    Multi-project, indication-agnostic framework covering biobanking, longitudinal follow-up, and secondary use
  • More than 10 clinical and outpatient centers under contract

Noselab Biobank

  • Comprehensive curated clinical data and well-characterized samples
  • More than 20 clinical conditions with curated clinical history, nasal fluid, CSF and plasma
  • Broadly analysed with proteomics and targeted assays
  • Proprietary data base allowing for efficient data mining

Data Modelling

  • Strong team covering all aspects of AI, data science, software and IT with established analytics data infrastructure
  • AI powered data analytics, discovery and modeling to enable biological and clinical insight generation

Target Applications

Minimally invasive, frequent sampling unlocks new possibilities

Longitudinal Disease / Treatment Monitoring

  • Nasal fluid sampling can be done frequently at outpatient care settings
  • Unlocking close surveillance of disease progression or therapy success

Pharmakokinetics and Dosing

  • Drug delivery to the brain can be monitored directly and/or indirectly by monitoring affected biomarkers
  • Unlocking more efficient studies and better therapies

Minimally-Invasive Biomarker Diagnostics

  • Quantification of disease-relevant biomarkers for early detection